Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W1WQ
|
||||
Former ID |
DNC005396
|
||||
Drug Name |
(R)-3-(4-Isobutyl-phenyl)-butan-2-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527602] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H20O
|
||||
Canonical SMILES |
CC(C)CC1=CC=C(C=C1)C(C)C(=O)C
|
||||
InChI |
1S/C14H20O/c1-10(2)9-13-5-7-14(8-6-13)11(3)12(4)15/h5-8,10-11H,9H2,1-4H3/t11-/m0/s1
|
||||
InChIKey |
VOYZJYGIHFRNAG-NSHDSACASA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | High affinity interleukin-8 receptor A | Target Info | Inhibitor | [527602] | |
High affinity interleukin-8 receptor B | Target Info | Inhibitor | [527602] | ||
NetPath Pathway | IL2 Signaling PathwayNetPath_9:TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | IL8- and CXCR1-mediated signaling eventsil8cxcr2_pathway:IL8- and CXCR2-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.